Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / internal-strategy-memo-termination.docx
internal-strategy-memo-termination.docx
High · 0
Medium · 4
Standard · 3
I. Executive Summary
Medium
⚑ Confidentiality undertaking
I. Executive Summary This memorandum analyzes the legal position and available strategic options for our client, Lumos Analytics Inc. ("Lumos" or the "Company"), following the October 15, 2023 request by Vantage Peak Ventures Fund II, L.P. ("Vantage Peak") for the return of its $3,500,000 investment under a Simple Agreement for Future Equity ("SAFE"), citing alleged material misrepresentation regarding the readiness
II. Factual Background
Standard
⚑ Commercial term
II. Factual Background A. The SAFE Financing Round Lumos Analytics Inc. is a Delaware C-corporation (EIN: 87-3491026; Delaware Secretary of State File No. 7394821), headquartered at 340 Folsom Street, Suite 1100, San Francisco, CA 94105. The Company is a seed-stage SaaS/fintech analytics company operating in the financial regulatory compliance and predictive risk scoring space. Lumos was incorporated in Delaware in 2
III. Analysis of SAFE Termination Provisions
Medium
⚑ Confidentiality undertaking
III. Analysis of SAFE Termination Provisions A. Structure of the Post-Money SAFE The SAFE instruments executed with Vantage Peak, Ridgeline, and Canopy Growth are based on the YC standard Post-Money SAFE form, with certain modifications negotiated during the September 2023 documentation process. As a threshold matter, it is important to understand the structural characteristics of the SAFE instrument that are relevan
IV. Contractual and Equitable Refund Obligations
Standard
⚑ Commercial term
IV. Contractual and Equitable Refund Obligations A. Contractual Basis for Refund As established in Section III above, no express refund obligation exists under the terms of the executed SAFEs outside of a Dissolution Event. The SAFEs do not contain any provision entitling an investor to demand return of the purchase amount based on product setbacks, failure to meet development milestones, material adverse changes in
V. Fraud and Misrepresentation Exposure Under Delaware Law
Standard
⚑ Commercial term
V. Fraud and Misrepresentation Exposure Under Delaware Law A. The Alleged Misrepresentation The core factual predicate for Vantage Peak's misrepresentation claim is the representation made in Lumos's August 2023 investor pitch materials that Prism Core v2.0 would be "beta-ready by Q4 2023." This representation appeared in the product roadmap section of the pitch deck that was circulated to Vantage Peak and other pros
VI. Risk Assessment — Litigation Exposure
Medium
⚑ Forum / governing law
VI. Risk Assessment — Litigation Exposure A. Probability of Litigation If Lumos refuses to refund the SAFE purchase amounts or offers only a partial refund, the probability of formal litigation is high. Vantage Peak has already retained Whitfield Harte & Associates LLP, a firm with significant venture capital litigation experience, which signals a serious intent to pursue legal remedies if a negotiated resolution is
VII. Treatment of Atlas Fintech Syndicate
VII. Treatment of Atlas Fintech Syndicate Atlas Fintech Syndicate, L.P. signed a non-binding term sheet on October 4, 2023, committing $1,000,000 to the seed financing round. However, the SAFE between Lumos and Atlas Fintech was never executed, and no funds were transferred. The term sheet expressly provides that it is non-binding and does not create any legal obligation on the part of either party to consummate the
VIII. Treatment of Co-Investor SAFEs (Ridgeline and Canopy Growth)
Medium
⚑ Forum / governing law
VIII. Treatment of Co-Investor SAFEs (Ridgeline and Canopy Growth) The Ridgeline Angel Fund, L.P. SAFE ($1,200,000, executed September 22, 2023) and the Canopy Growth Capital LLC SAFE ($1,100,000, executed September 29, 2023) are on identical substantive terms as the Vantage Peak SAFE, including the same $28,000,000 post-money valuation cap, no discount, MFN provision, conversion triggers, and governing law. The same